Celldex Therapeutics(CLDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLDX Celldex Therapeutics

Trading 10-08 14:56:44 EDT

29.22

-1.21

-3.98%

High30.07	Low28.64	Vol1.96M
Open30.07	D1 Closing30.43	Amplitude4.70%
Mkt Cap2.29B	Tradable Cap2.13B	Total Shares78.49M
T/O57.10M	T/O Rate2.68%	Tradable Shares73.02M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLDX","market":"US","secType":"STK","nameCN":"Celldex Therapeutics","latestPrice":29.22,"timestamp":1791485803256,"preClose":30.43,"halted":0,"volume":1960344,"delay":0,"changeRate":-0.03976339139007561,"floatShares":73018600,"shares":78492100,"eps":-4.340134,"marketStatus":"Trading","change":-1.21,"latestTime":"10-08 14:56:44 EDT","open":30.07,"high":30.07,"low":28.64,"amount":57102546.72096,"amplitude":0.046993,"askPrice":29.25,"askSize":402,"bidPrice":29.19,"bidSize":949,"shortable":3,"etf":0,"ttmEps":-4.340134,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":515304000000,"exchange":"NASDAQ","adjPreClose":30.43,"preHourTrading":{"tag":"盘前","latestPrice":30.43,"preClose":30.43,"latestTime":"09:26 EDT","volume":28784,"amount":875888.6287199999,"timestamp":1791465961112,"change":0,"changeRate":0,"amplitude":0.021525},"postHourTrading":{"tag":"盘后","latestPrice":30.51,"preClose":30.43,"latestTime":"19:30 EDT","volume":135350,"amount":4118720.22,"timestamp":1791415800684,"change":0.08,"changeRate":0.002629,"amplitude":0.002629},"volumeRatio":1.355832,"impliedVol":0.6587,"impliedVolPercentile":0.7649},"requestUrl":"/m/hq/s/CLDX/tweets","defaultTab":"tweets","newsList":[{"id":"2673084447","title":"How Investors May Respond To Celldex Therapeutics Stock After Phase 3 Trial Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084447","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084447?lang=en_us&edition=fundamental","pubTime":"2026-10-05 14:17","pubTimestamp":1791181022,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics reported positive topline data from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab in antihistamine-refractory chronic spontaneous urticaria, with both studies meeting the primary UAS7 endpoint and all key secondary measures and showing a safety profile consistent with prior Phase 2 data.\nThe trials included a large global cohort of 1,939 patients, with meaningful rates of complete symptom resolution, including in omalizumab-refractory subgroups, which...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cldx/celldex-therapeutics/news/how-investors-may-respond-to-celldex-therapeutics-stock-afte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cldx/celldex-therapeutics/news/how-investors-may-respond-to-celldex-therapeutics-stock-afte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","ISBC","CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672725083","title":"Celldex (CLDX) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2672725083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672725083?lang=en_us&edition=fundamental","pubTime":"2026-10-03 22:35","pubTimestamp":1791038111,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Celldex today and set a price target of $64.00. According to TipRanks, Slutsky is a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/celldex-cldx-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/celldex-cldx-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672123857","title":"Celldex adverse event concerns overblown, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2672123857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672123857?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:50","pubTimestamp":1790945435,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis says the Celldex (CLDX) bear case is trying “death by a thousand cuts.” Concerns are bouncing from one adv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celldex-adverse-event-concerns-overblown-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celldex-adverse-event-concerns-overblown-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714708","title":"Celldex Therapeutics Price Target Maintained with a $64.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714708","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714708?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:47","pubTimestamp":1790945220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLDX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670165285","title":"Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Holdings (SENS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670165285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670165285?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:40","pubTimestamp":1790570421,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Hol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celldex-cldx-nanobiotix-nbtx-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celldex-cldx-nanobiotix-nbtx-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CLDX","LABU","SENS","BK4585","BK4082","BK4581","XBI","LU0029874061.USD","BK4139","BK4588","LU0128526141.USD","HCSG","XLV","NBTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669343653","title":"Belgium's Celyad H1 Net Loss Narrows on Lower Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2669343653","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669343653?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:14","pubTimestamp":1790194483,"startTime":"0","endTime":"0","summary":"Belgium's Celyad H1 net loss narrows on lower expensesOverviewBelgium biotechnology firm's first half 2026 net loss narrowed on reduced expensesCompany posted no revenue for first half 2026, consisten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL1N45F0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IONS","BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348488","title":"Canaccord Genuity Sticks to Their Buy Rating for Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669348488?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:16","pubTimestamp":1790162162,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Edward Nash reiterated a Buy rating on Celldex today and set a price target of $60.00. Nash covers the Healthcare sector,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100966","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669100966?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:50","pubTimestamp":1790160625,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Celldex (CLDX) and Inventiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-celldex-cldx-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-celldex-cldx-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","BK4516","LU1983299246.USD","LU1585245621.USD","LU0320765489.SGD","LU2125154935.USD","LU0203345920.USD","SG9999014559.SGD","LU0985320562.USD","LU0289961442.SGD","LU1162221912.USD","LU0265550359.USD","IE00BBT3K403.USD","LU0823416689.USD","LU0006306889.USD","LU1291159041.SGD","SG9999013999.USD","LU0289739343.SGD","LU1934455194.USD","LU0130517989.USD","IVA","IE00BSNM7G36.USD","LU0868494708.USD","LU1571399168.USD","LU2433249047.HKD","MRK","LU2491049909.HKD","LU2106854487.HKD","LU0965508806.USD","LU0868494617.USD","LU2324357040.USD","LU1069347547.HKD","LU1116320737.USD","LU2125909247.SGD","LU0057025933.USD","IE000M9KFDE8.USD","LU0432979614.USD","LU1974910355.USD","LU2361045086.USD","LU0689626769.HKD","LU1093756325.SGD","LU0072461881.USD","LU0211331839.USD","SGXZ57979304.SGD","LU1923622614.USD","LU1989772840.SGD","HRTS","LU0265550946.USD","LU0965509101.SGD","LU0320765646.SGD","PAWZ","LU2360032135.SGD","LU2125154778.USD","LU1061106388.HKD","IHE","LU0234572021.USD","LU0980610538.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0203347892.USD","LU0069063385.USD","BK4534","SG9999014575.USD","LU1023059063.AUD","LU2023250843.SGD","LU0289739699.SGD","LU1037948897.HKD","LU1037948541.HKD","LU1699723380.USD","SG9999014542.SGD","LU0477156953.USD","SG9999014567.USD","IE00BFTCPJ56.SGD","LU1035773651.USD","BK4588","LU0130102774.USD","LU0861579265.USD","LU2023250504.SGD","VHT","BK4559","IE00B4R5TH58.HKD","LU0238689110.USD","BK4533","LU1917777945.USD","LU1066051811.HKD","SG9999015341.SGD","SG9999002224.SGD","LU2361044949.HKD","LU2089984988.USD","LU2491050154.USD","JDOC","SG9999001176.USD","LU2112291526.USD","BK4007","SG9999015358.SGD","LU0965509010.AUD","LU1066053197.SGD","BK4139","LU0208291251.USD","LU0162691827.USD","IYH","FTXH","LU1066051225.USD","IE00BLSP4239.USD","LU0965509283.SGD","LU1934455277.USD","LU0058720904.USD","LU1032466523.USD","LU1989772923.USD","LU0070302665.USD","LU1093756168.USD","LU1929549753.HKD","LU0472753341.HKD","LU1934455863.HKD","IE00BN8TJ469.HKD","FHLC","IE0002141913.USD","IE00B2B36J28.USD","LU0124676726.USD","IXJ","LU1989771016.USD","SG9999002232.USD","LU0106261372.USD","LU1066051498.USD","LU1116320901.HKD","LU2468319806.SGD","PPH","LU2491050071.SGD","LU0859254822.USD","TRUH","LU1430594728.SGD","BK4585","LU0511384066.AUD","IE00B1BXHZ80.USD","LU1201861249.SGD","LU2125909593.SGD","CLDX","LU0942090050.USD","IE00BJT1NW94.SGD","LU0098860793.USD","LU0122379950.USD","LU1057294990.SGD","BK4550","LU1941712264.USD","LU2461242641.AUD","LU0266013472.USD","GDOC","LU2357627491.SGD","RXL","LU0648001328.SGD","SG9999001176.SGD","IE00BLSP4452.SGD","LU1941712348.USD","BMED","LU2361044865.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669001091","title":"Wells Fargo Keeps Their Buy Rating on Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669001091","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669001091?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:45","pubTimestamp":1790160331,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Derek Archila maintained a Buy rating on Celldex yesterday and set a price target of $72.00. The company’s shares closed yester...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-keeps-their-buy-rating-on-celldex-cldx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-keeps-their-buy-rating-on-celldex-cldx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669105916","title":"US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669105916","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669105916?lang=en_us&edition=fundamental","pubTime":"2026-09-23 15:36","pubTimestamp":1790149013,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP- Allstate, Autozone, Vertex PharmaceuticalsSept 23 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Allst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4N45F0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLY","STZ","ANAB","HUTG","CORZ","WFRD","HII","ARDT","NATO","SHLD","CYH","AMGN","CIFR","ACHC","GD","GE","CMI","GPK","HUT","DFEN","BSVN","FOXA","AZO","BLCK","PKB","CRMD","HBAN","APLD","HCA","BDC","CBZ","CLDX","CRWV","EXI","FITB","PBE","AMRZ","CWVX","CCL","GRDN","CFG","AXP","ALL","COLL","AMRX","CMPX","DCH","ANIX","CRWG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669812146","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2669812146","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669812146?lang=en_us&edition=fundamental","pubTime":"2026-09-23 02:49","pubTimestamp":1790102956,"startTime":"0","endTime":"0","summary":"Treasure Global (TGL) said Tuesday its Tadaa Technology unit has formed a partnership with Malaysia-based Kainan to provide AI-enabled technology services for a planned $367 million solar farm project","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TGL","BK4009","BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669080123","title":"Celldex Therapeutics is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2669080123","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669080123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:43","pubTimestamp":1790091780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLDX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669237741","title":"U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify","url":"https://stock-news.laohu8.com/highlight/detail?id=2669237741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669237741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:41","pubTimestamp":1790091697,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, ShopifySeptember 22 (Reuters)-The tech-heavy Nasdaq hit an intraday record high for the first time since early June on Tuesday, underpinned by s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL6N45E0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VICR","KMI","FLNA","RIOT","RJF","THO","CMPX","VRTX","SCHW","SF","ZEO","GME","MLKN","CLDX","AMGN","DCOY","CXT","DAVA","MARA","BFLY","CONY","SOS","CW","AZO","GEMI","AMP","COIN","ODDS","USNG","OKE","SHOP","SHPU","VLO","EPD","HUT","GOOGL","ONON","HUBC","VKTX","RSI","BTTC","ET","GRML","DNA","MPWR","MRNA","SLXN","LEN","EAF","MSFT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123735","title":"Celldex price target raised to $64 from $42 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123735?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:30","pubTimestamp":1790091012,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis raised the firm’s price target on Celldex (CLDX) to $64 from $42 and keeps a Buy rating on the shares afte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celldex-price-target-raised-to-64-from-42-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celldex-price-target-raised-to-64-from-42-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669238111","title":"Celldex Shares Slip as Safety Concerns Cloud Skin Drug Trial Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2669238111","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669238111?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:02","pubTimestamp":1790089344,"startTime":"0","endTime":"0","summary":"UPDATE 1-Celldex shares slip as safety concerns cloud skin drug trial winSept 22 (Reuters)-Celldex Therapeutics said on Tuesday its experimental drug significantly reduced disease activity in two late","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0U6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128031","title":"Celldex Falls After Two Probable Anaphylaxis Cases in Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128031","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128031?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:58","pubTimestamp":1790089105,"startTime":"0","endTime":"0","summary":"BUZZ-Celldex falls after two probable anaphylaxis cases in trials** Shares of Celldex TherapeuticsCLDX.Odown 12.8% to $33.07, set for its biggest one-day fall in just over a year** The biotech company","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL6N45E0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140776","title":"Celldex falls -5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140776","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140776?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:05","pubTimestamp":1790085954,"startTime":"0","endTime":"0","summary":"Celldex (CLDX) is down -5.1%, or -$1.92 to $35.97. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celldex-falls-5-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celldex-falls-5-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669471931","title":"Celldex Therapeutics Shares Fall 1.9% After Data from Late-Stage Trials of Its Skin Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669471931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669471931?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:35","pubTimestamp":1790084150,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144643","title":"Celldex Therapeutics Shares Reverse Course; Last Down 19.2% Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144643?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:28","pubTimestamp":1790080093,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL1N45E0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146417","title":"Celldex Therapeutics Shares up 21% Premarket After Co's Skin Condition Drug Barzolvolimab Meets Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146417?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:09","pubTimestamp":1790075357,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.celldex.com","stockEarnings":[{"period":"1week","weight":-0.0611},{"period":"1month","weight":-0.2331},{"period":"3month","weight":-0.2193},{"period":"6month","weight":-0.0561},{"period":"1year","weight":0.1606},{"period":"ytd","weight":0.1204}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.123409},{"month":2,"riseRate":0.425,"avgChangeRate":-0.00139},{"month":3,"riseRate":0.475,"avgChangeRate":0.004594},{"month":4,"riseRate":0.5,"avgChangeRate":0.003159},{"month":5,"riseRate":0.275,"avgChangeRate":-0.021672},{"month":6,"riseRate":0.512195,"avgChangeRate":0.146914},{"month":7,"riseRate":0.439024,"avgChangeRate":-0.012125},{"month":8,"riseRate":0.390244,"avgChangeRate":-0.026248},{"month":9,"riseRate":0.317073,"avgChangeRate":-0.022185},{"month":10,"riseRate":0.487805,"avgChangeRate":0.00306},{"month":11,"riseRate":0.575,"avgChangeRate":0.057317},{"month":12,"riseRate":0.45,"avgChangeRate":-0.008619}],"exchange":"NASDAQ","name":"Celldex Therapeutics","nameEN":"Celldex Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Celldex Therapeutics(CLDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Celldex Therapeutics(CLDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Celldex Therapeutics,CLDX,Celldex Therapeutics股票,Celldex Therapeutics股票老虎,Celldex Therapeutics股票老虎国际,Celldex Therapeutics行情,Celldex Therapeutics股票行情,Celldex Therapeutics股价,Celldex Therapeutics股市,Celldex Therapeutics股票价格,Celldex Therapeutics股票交易,Celldex Therapeutics股票购买,Celldex Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Celldex Therapeutics(CLDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Celldex Therapeutics(CLDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction